PRRT2 and autoimmune disease: PKCθ−/− mice exhibit reduced T cell activation, proliferation and IL-2 production downstream of T-cell receptor stimulation, owing to markedly reduced activation of multiple transcription factors [16], [17] and, as a result, these mice are resistant to some models of autoimmune disease [18]–[20].